Antibody-Mediated Targeting of Iron Oxide Nanoparticles to the Folate Receptor Alpha Increases Tumor Cell Association in Vitro and in Vivo

International Journal of Nanomedicine- New Zealand

doi 10.2147/ijn.s79367

Full Text

Abstract

Available in

Date

April 1, 2015

Authors

Publisher

Informa UK Limited

Related search

Linker-Free Conjugation and Specific Cell Targeting of Antibody Functionalized Iron-Oxide Nanoparticles

Journal of Materials Chemistry B

Medicine

Materials Science

Chemistry

Biomedical Engineering

2014

English

Single Chain Epidermal Growth Factor Receptor Antibody Conjugated Nanoparticles for in Vivo Tumor Targeting and Imaging

English

Expression of P2X7 Receptor Increases in Vivo Tumor Growth

Cancer Research

Oncology

2012

English

Lentivirus-Mediated RNA Interference Targeting WWTR1 in Human Colorectal Cancer Cells Inhibits Cell Proliferation in Vitro and Tumor Growth in Vivo

English

Functionalization of Iron Oxide Magnetic Nanoparticles With the Multivalent Pseudopeptide N6l for Breast Tumor Targeting

Journal of Nanomedicine & Nanotechnology

2015

English

Derlin-1 Is Overexpressed on the Tumor Cell Surface and Enables Antibody-Mediated Tumor Targeting Therapy

Clinical Cancer Research

Cancer Research

Oncology

2008

English

Targeting Interleukin-11 Receptor- Impairs Human Endometrial Cancer Cell Proliferation and Invasion in Vitro and Reduces Tumor Growth and Metastasis in Vivo

Molecular Cancer Therapeutics

Cancer Research

Oncology

2016

English

Targeting Cell Adhesion Molecules With Nanoparticles Using in Vivo and Flow-Based in Vitro Models of Atherosclerosis

Experimental Biology and Medicine

English

VEGFR Targeting Leads to Significantly Enhanced Tumor Uptake of Nanographene Oxide in Vivo

Biomaterials

Mechanics of Materials

English

Amanote Research

Antibody-Mediated Targeting of Iron Oxide Nanoparticles to the Folate Receptor Alpha Increases Tumor Cell Association in Vitro and in Vivo

International Journal of Nanomedicine- New Zealand

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Linker-Free Conjugation and Specific Cell Targeting of Antibody Functionalized Iron-Oxide Nanoparticles

Single Chain Epidermal Growth Factor Receptor Antibody Conjugated Nanoparticles for in Vivo Tumor Targeting and Imaging

Expression of P2X7 Receptor Increases in Vivo Tumor Growth

Lentivirus-Mediated RNA Interference Targeting WWTR1 in Human Colorectal Cancer Cells Inhibits Cell Proliferation in Vitro and Tumor Growth in Vivo

Functionalization of Iron Oxide Magnetic Nanoparticles With the Multivalent Pseudopeptide N6l for Breast Tumor Targeting

Derlin-1 Is Overexpressed on the Tumor Cell Surface and Enables Antibody-Mediated Tumor Targeting Therapy

Targeting Interleukin-11 Receptor- Impairs Human Endometrial Cancer Cell Proliferation and Invasion in Vitro and Reduces Tumor Growth and Metastasis in Vivo

Targeting Cell Adhesion Molecules With Nanoparticles Using in Vivo and Flow-Based in Vitro Models of Atherosclerosis

VEGFR Targeting Leads to Significantly Enhanced Tumor Uptake of Nanographene Oxide in Vivo